Xiaofeng Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaofeng Hu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Pan Zhao
Department of General Surgery Mianyang Hospital of Traditional Chinese Medicine Mianyang Sichuan China
3 shared publicationsYunshen He
Department of General Surgery Mianyang Hospital of Traditional Chinese Medicine Mianyang Sichuan China
3 shared publicationsZhenghong Huang
Medical Insurance Department Youxian District People's Hospital Mianyang Sichuan China
3 shared publicationsKun Huang
Department of General Surgery, Mian Yang Hospital of Traditional Chinese Medicine, Mianyang, P.R. China
2 shared publications- Kun Huang
Department of General Surgery Mianyang Hospital of Traditional Chinese Medicine Mianyang Sichuan China
1 shared publication
Latest Publications
- 15 July 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (5) , e70205
New‐Onset Diabetes and Pancreatic Ductal Adenocarcinoma: Implications for Early Recognition and Clinical Management
Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal because most patients are diagnosed after curative treatment is no longer feasible. Diabetes mellitus and PDAC have a bidirectional relationship: long‐standing type 2 diabetes mellitus (T2DM) modestly increases background cancer risk, whereas new‐onset diabetes (NOD), particularly after 50 years of age, may represent a paraneoplastic manifestation of occult PDAC. Population‐based data suggest that approximately 0.6%–0.85% of older adults with NOD are diagnosed with PDAC within 3 years. This absolute risk is too low to justify universal imaging, but high enough to support phenotype‐based triage. This review clarifies the distinction among T2DM, PDAC‐associated diabetes, type 3c diabetes mellitus related to non‐malignant exocrine pancreatic disease, and post‐pancreatectomy dysglycemia. We also summarise epidemiological and biological evidence connecting dysglycemia with PDAC, including insulin resistance, hyperinsulinemia, impaired insulin secretion, cachexia‐related metabolic change, and exocrine‐endocrine crosstalk. Particular emphasis is placed on selective diagnostic escalation. Age at diabetes onset, unintended weight loss, HbA1c or glucose trajectory, insulin resistance indices, biomarkers, and risk‐enrichment models, including the Enriching New‐Onset Diabetes for Pancreatic Cancer (END‐PAC) model, should be interpreted together rather than in isolation. Pancreas‐protocol computed tomography remains the first‐line diagnostic study when PDAC is suspected, while magnetic resonance imaging and endoscopic ultrasonography play complementary roles. We further discuss implications for pancreatic surgery, perioperative metabolic care, postoperative dysglycemia, and lessons from high‐risk surveillance cohorts. A diabetes‐centred framework may improve early recognition without promoting indiscriminate screening.
- 15 July 2026
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 42 (5) , e70205
New‐Onset Diabetes and Pancreatic Ductal Adenocarcinoma: Implications for Early Recognition and Clinical Management
Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal because most patients are diagnosed after curative treatment is no longer feasible. Diabetes mellitus and PDAC have a bidirectional relationship: long‐standing type 2 diabetes mellitus (T2DM) modestly increases background cancer risk, whereas new‐onset diabetes (NOD), particularly after 50 years of age, may represent a paraneoplastic manifestation of occult PDAC. Population‐based data suggest that approximately 0.6%–0.85% of older adults with NOD are diagnosed with PDAC within 3 years. This absolute risk is too low to justify universal imaging, but high enough to support phenotype‐based triage. This review clarifies the distinction among T2DM, PDAC‐associated diabetes, type 3c diabetes mellitus related to non‐malignant exocrine pancreatic disease, and post‐pancreatectomy dysglycemia. We also summarise epidemiological and biological evidence connecting dysglycemia with PDAC, including insulin resistance, hyperinsulinemia, impaired insulin secretion, cachexia‐related metabolic change, and exocrine‐endocrine crosstalk. Particular emphasis is placed on selective diagnostic escalation. Age at diabetes onset, unintended weight loss, HbA1c or glucose trajectory, insulin resistance indices, biomarkers, and risk‐enrichment models, including the Enriching New‐Onset Diabetes for Pancreatic Cancer (END‐PAC) model, should be interpreted together rather than in isolation. Pancreas‐protocol computed tomography remains the first‐line diagnostic study when PDAC is suspected, while magnetic resonance imaging and endoscopic ultrasonography play complementary roles. We further discuss implications for pancreatic surgery, perioperative metabolic care, postoperative dysglycemia, and lessons from high‐risk surveillance cohorts. A diabetes‐centred framework may improve early recognition without promoting indiscriminate screening.
- Open Access
- 13 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Association of surgery with survival in small cell carcinoma of the digestive system: a population-based observational study using machine learning
To evaluate the association of surgery with survival outcomes in patients with small cell carcinoma of the digestive system (SCCDS) using data from the Surveillance, Epidemiology, and End Results (SEER) database and machine-learning-based analysis. Data from patients with SCCDS diagnosed between 2000 and 2018 were extracted from the SEER database. After applying the inclusion and exclusion criteria, 1600 eligible patients were included. Patients were categorized into surgery and non-surgery groups. Overall survival (OS) and cancer-specific survival (CSS) were assessed using Kaplan-Meier analysis and Cox proportional hazards models. To further reduce treatment selection bias, propensity score-based inverse probability of treatment weighting (IPTW) was performed as a sensitivity analysis. A random forest algorithm was used to identify important prognostic factors. Subgroup analyses were conducted to explore the association between surgery and survival across different patient subsets. The surgery group (n = 400) showed better unadjusted 1-year OS (52.69% vs. 32.82%) and CSS (55.40% vs. 35.12%) than the non-surgery group (n = 1200; both P < 0.001). Multivariable Cox regression identified age, sex, tumor stage, hepatic metastasis, radiotherapy, chemotherapy, and surgery as independent prognostic factors for OS and CSS (all P < 0.05). In IPTW analyses, surgery remained independently associated with better OS and CSS. Machine learning analysis further identified surgery, tumor stage, and hepatic metastasis as major contributors to survival prediction. Subgroup analysis suggested that the association between surgery and survival may be less evident in patients with esophageal or retroperitoneal tumors and in Asian or Pacific Islander populations. Surgery was independently associated with better OS and CSS in patients with SCCDS. However, given the retrospective design and the potential for residual confounding, these findings should be interpreted cautiously. The survival association of surgery may be less pronounced in certain subgroups, highlighting the importance of careful patient selection.
- 13 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAssociation of surgery with survival in small cell carcinoma of the digestive system: a population-based observational study using machine learning
To evaluate the association of surgery with survival outcomes in patients with small cell carcinoma of the digestive system (SCCDS) using data from the Surveillance, Epidemiology, and End Results (SEER) database and machine-learning-based analysis. Data from patients with SCCDS diagnosed between 2000 and 2018 were extracted from the SEER database. After applying the inclusion and exclusion criteria, 1600 eligible patients were included. Patients were categorized into surgery and non-surgery groups. Overall survival (OS) and cancer-specific survival (CSS) were assessed using Kaplan-Meier analysis and Cox proportional hazards models. To further reduce treatment selection bias, propensity score-based inverse probability of treatment weighting (IPTW) was performed as a sensitivity analysis. A random forest algorithm was used to identify important prognostic factors. Subgroup analyses were conducted to explore the association between surgery and survival across different patient subsets. The surgery group (n = 400) showed better unadjusted 1-year OS (52.69% vs. 32.82%) and CSS (55.40% vs. 35.12%) than the non-surgery group (n = 1200; both P < 0.001). Multivariable Cox regression identified age, sex, tumor stage, hepatic metastasis, radiotherapy, chemotherapy, and surgery as independent prognostic factors for OS and CSS (all P < 0.05). In IPTW analyses, surgery remained independently associated with better OS and CSS. Machine learning analysis further identified surgery, tumor stage, and hepatic metastasis as major contributors to survival prediction. Subgroup analysis suggested that the association between surgery and survival may be less evident in patients with esophageal or retroperitoneal tumors and in Asian or Pacific Islander populations. Surgery was independently associated with better OS and CSS in patients with SCCDS. However, given the retrospective design and the potential for residual confounding, these findings should be interpreted cautiously. The survival association of surgery may be less pronounced in certain subgroups, highlighting the importance of careful patient selection.
- Open Access
- 5 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Association of surgical resection with survival in retroperitoneal leiomyosarcoma based on SEER propensity score matching and machine-learning models
Retroperitoneal leiomyosarcoma (RLS) is a rare and aggressive subtype of soft tissue sarcoma with limited population-level evidence guiding surgical decision-making. This study aimed to assess the prognostic value of surgery in patients with RLS using a large real-world cohort and advanced analytical methods. Patients diagnosed with RLS between 2000 and 2019 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM) was used to balance baseline variables. Overall survival (OS) and cancer-specific survival (CSS) were analyzed using Kaplan–Meier curves and Cox proportional hazards models. Random survival forests (RSF) were applied to evaluate variable importance and model robustness. A total of 1041 patients were included, of whom 817 (78.5%) underwent surgery. Before matching, significant imbalances were observed in age, grade, and SEER stage. After 1:1 PSM (159 matched pairs), covariate balance was substantially improved. Surgery was associated with significantly improved survival (OS: HR = 0.34, 95% CI: 0.26–0.45; CSS: HR = 0.34, 95% CI: 0.25–0.46; both P < 0.001). High-grade tumors and advanced SEER stage remained independent adverse prognostic factors. RSF consistently ranked surgery, stage, and grade as the most important predictors of survival. Surgical resection status was strongly associated with survival in SEER-based analyses, but this association is subject to substantial unmeasured confounding by resectability, anatomic extent, and patient fitness; therefore, results should be interpreted as prognostic rather than causal and highlight the need for multidisciplinary assessment in high-volume sarcoma centers.
- 5 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAssociation of surgical resection with survival in retroperitoneal leiomyosarcoma based on SEER propensity score matching and machine-learning models
Retroperitoneal leiomyosarcoma (RLS) is a rare and aggressive subtype of soft tissue sarcoma with limited population-level evidence guiding surgical decision-making. This study aimed to assess the prognostic value of surgery in patients with RLS using a large real-world cohort and advanced analytical methods. Patients diagnosed with RLS between 2000 and 2019 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM) was used to balance baseline variables. Overall survival (OS) and cancer-specific survival (CSS) were analyzed using Kaplan–Meier curves and Cox proportional hazards models. Random survival forests (RSF) were applied to evaluate variable importance and model robustness. A total of 1041 patients were included, of whom 817 (78.5%) underwent surgery. Before matching, significant imbalances were observed in age, grade, and SEER stage. After 1:1 PSM (159 matched pairs), covariate balance was substantially improved. Surgery was associated with significantly improved survival (OS: HR = 0.34, 95% CI: 0.26–0.45; CSS: HR = 0.34, 95% CI: 0.25–0.46; both P < 0.001). High-grade tumors and advanced SEER stage remained independent adverse prognostic factors. RSF consistently ranked surgery, stage, and grade as the most important predictors of survival. Surgical resection status was strongly associated with survival in SEER-based analyses, but this association is subject to substantial unmeasured confounding by resectability, anatomic extent, and patient fitness; therefore, results should be interpreted as prognostic rather than causal and highlight the need for multidisciplinary assessment in high-volume sarcoma centers.